INTRODUCTION {#sec0005}
============

Type 2 diabetes mellitus (hereafter referred to as diabetes) and prediabetes have been associated with an increased risk of cognitive impairment, accelerated cognitive decline, and dementia among older adults \[[@ref001]\]. Yet, the cognitive effect of diabetes in non--demented elderly people, especially the initial phases of deterioration related to diabetes, remain insufficiently explored.

Previous research indicates that diabetes is related to decrements in several cognitive domains, including processing speed \[[@ref002]\]. Other studies on the association of diabetes with different components of executive functions and memory have reported both positive and negative findings \[[@ref003]\]. Discrepancies among studies may reflect differences in study design, the inclusion of people with cognitive impairment and dementia, heterogeneity of tasks for assessing cognitive functions, and a lack of consideration of prediabetes, glycemic control, vascular risk factors (VRFs), and vascular disorders. Apolipoprotein *ɛ*4 allele (*APOE* *ɛ*4) is an established risk factor for late--onset Alzheimer's disease, and this allele can also exacerbate the harmful effect of diabetes on cognitive functioning \[[@ref005]\]. Further research is needed with regard to which factors may modulate the association between diabetes and cognitive functioning.

Thus, in this study we explored: 1) which cognitive domains are impaired early in diabetes; and 2) whether glycemic control, VRFs, vascular disorders, and *APOE* status modulate the association between diabetes and cognitive functioning among dementia--and cognitive impairment--free older adults.

MATERIAL AND METHODS {#sec0010}
====================

Study population {#sec0015}
----------------

Study participants were derived from the baseline assessment in the population--based Swedish National Study on Aging and Care--Kungsholmen (SNAC--K) \[[@ref006]\]. The study population consists of a random sample of individuals aged ≥60 years living at home or in institutions in the Kungsholmen district, Stockholm, Sweden. Of the 5111 persons initially invited for participation, 4590 were alive and eligible at baseline and 3363 (73.3%) agreed to be part of the baseline survey (March 2001 through June 2004). In order to investigate the early cognitive deficits associated with diabetes, participants with dementia, preclinical dementia, and cognitive impairment--no dementia (CIND) were excluded. Thus, the current study included 2305 participants who performed the cognitive protocol and were cognitively intact ([Fig. 1](#jad-53-jad160266-g001){ref-type="fig"}). SNAC--K was approved by the Regional Ethical Review Board in Stockholm, Sweden. Written informed consent was obtained from all participants and, in the case of cognitive impairment, from a proxy (i.e., a close family member or guardian).

Data collection {#sec0020}
---------------

Data on personal characteristics (i.e., age, sex, and education), lifestyle factors (smoking, alcohol consumption, and physical activity), systolic and diastolic blood pressure (SBP and DBP, respectively), and anthropometrics (i.e., height and weight), were collected through interviews and measurements by nurses following a structured protocol (available at http://www.snac.org). A comprehensive clinical examination was conducted by physicians, and trained psychologists assessed cognitive performance.

Educational level was measured as the maximum years of formal schooling and defined as low (≤8 years) or high (\>8 years). Body mass index (BMI) was calculated as weight in kilograms divided by squared height in meters (kg/m^2^) and categorized into four groups: underweight (\<18.5), normal weight (18.5--25), overweight (25--30), and obese (≥30). Arterial blood pressure was measured twice at a 5-min interval on the left arm in a sitting position with a sphygmomanometer; the mean of the two readings was used. Alcohol consumption was categorized into no/occasional or drinking (including light-to-moderate and heavy drinking), on the basis of frequency and amount of drinks on a typical drinking day. Smoking status was dichotomized as non-smoking (those who had never smoked or were former smokers) or current smoking. VRFs included smoking and overweight/obese (BMI ≥25). Physical activity was dichotomized as physically inactive (≤2--3 times per month of light-to-intense exercise) or physically active (participating in health- or fitness-enhancing exercise several times per week or every day) \[[@ref006]\].

Information on medical conditions was available through the inpatient registry (IR) system that covers all hospitalizations in Stockholm since 1969. The criteria of the ninth and tenth revisions of the International Classification of Diseases (ICD-- 9 and ICD-- 10) were used. Medical drugs were collected in SNAC--K and classified according to the Anatomical Therapeutic Chemical (ATC) classification system. Medical conditions were ascertained on the basis of clinical examinations, self-reported medical histories, and the IR. Vascular disorders included hypertension, heart disease (arrhythmia, heart failure, coronary heart disease, and atrial fibrillation), and stroke. Hypertension was defined as ≥140/90 mmHg or the use of antihypertensive drugs (ATC codes C02, C03, and C07) and categorized as controlled (SBP \<140 mmHg or DBP \<90 mmHg) or uncontrolled (SBP ≥140 mmHg or DBP ≥90 mmHg) \[[@ref007]\]. Depression was diagnosed according to ICD-10 criteria \[[@ref009]\]. Peripheral blood samples were taken from all participants to determine *APOE* allelic status that was dichotomized into any *ɛ*4 carriers or *ɛ*4 non--carriers.

Assessment of diabetes and prediabetes {#sec0025}
--------------------------------------

Glycated hemoglobin (HbA1c) was measured using the Swedish Mono--S High Performance Liquid Chromatography. In accordance with the National Glycohemoglobin Standardization Program, 1.1% was added to the HbA1c value to equate them to international values \[[@ref010]\]. Diabetes was ascertained based on medical history, IR (ICD-- 9 code 250 and ICD-- 10 code E11), use of hypoglycemic medications (ATC code A10), or HbA1c \>6.4% (46 mmol/mol) \[[@ref011]\]. Prediabetes was defined as HbA1c of 5.7--6.4% (39--46 mmol/mol) in diabetes-free participants \[[@ref011]\]. Participants with diabetes were classified as controlled (HbA1c 5.7--6.4%) or uncontrolled (HbA1c \>6.4%). Duration of diabetes was calculated as the difference between chronological age at the baseline survey and the age at diagnosis, and dichotomized as short-term (\<10 years) or long-term (≥10 years).

Dementia diagnosis and definition of cognitive impairment-no dementia {#sec0030}
---------------------------------------------------------------------

Global cognitive functioning was assessed with the Mini-Mental State Examination (MMSE). Dementia was diagnosed following *The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM*-*IV)* criteria, using a validated three--step procedure \[[@ref012]\]. Two physicians independently made a preliminary diagnosis and, in case of disagreement, a third opinion was sought to reach a concordant diagnosis. Preclinical dementia referred to those participants who developed dementia during the first follow-up (which occurred after 6 years for cohorts 60--72 years and 3 years for cohorts aged ≥78 years, due to higher attrition among the older participants).

CIND is defined as a state in which a non-demented person shows significant global cognitive deficits. CIND was identified if the MMSE score was ≥2 standard deviations (SDs) below age- and education-specific means on the MMSE for participants aged 75 years \[[@ref013]\], and ≥1 SD below age- and education-specific means on the MMSE for participants aged ≥75 years \[[@ref015]\]. As the inter--individual variability in cognitive performance is high in older ages, we chose a more conservative cut-off (1 SD) for those aged 75 years and above to exclude participants with even slight global cognitive impairment.

Assessment of cognitive functions in different domains {#sec0035}
------------------------------------------------------

The cognitive assessment was comprised of a battery of 10 cognitive tests including domains of perceptual speed (digit cancellation, pattern comparison), category fluency (animals, professions), letter fluency (F and A), semantic memory (vocabulary, general knowledge), and episodic memory (word recall and recognition). Latent factor scores for these cognitive domains were generated using structural equation modeling (SEM)--- for a detailed description see Laukka et al. \[[@ref016]\]. Briefly, through SEM weights were derived to calculate the weighted means of the 10 cognitive tests to define the five cognitive domains \[[@ref016]\]. In addition, the digit span forward and backward tests were administered and their original scores were used to assess attention/primary memory and working memory, respectively \[[@ref017]\].

Statistical analyses {#sec0040}
--------------------

Multivariable linear regressions were used to estimate the mean difference (β-coefficients) with 95% confidence intervals (CIs) in cognitive performance among diabetes-free (reference), prediabetic, and diabetic persons. A separate linear regression model investigated the associations among diabetes-free participants (reference), prediabetes, controlled diabetes, and uncontrolled diabetes. Each cognitive domain was used as a separate outcome. Cognitive performance in each domain was divided into tertiles (low, middle, high). Multinomial logistic regressions were employed to examine the associations between diabetes and cognitive performance; in all models, the highest tertile (high performance) was used as reference category. Age, sex, education, vascular disorders, depression, *APOE* *ɛ*4, VRFs, physical activity, duration of diabetes, diabetes age--of--onset, and treatment of diabetes were considered as potential confounders.

Potential interactions between diabetes or glycemic control and factors such as smoking, overweight/obesity (BMI ≥ 25 kg/m^2^), vascular disorders, or *APOE* *ɛ*4, in predicting cognitive performance across domains were investigated. First, statistical interactions were examined by incorporating the two factors and their cross-product terms in the same model. For those analyses with significant interaction term, a stratified analysis by the factor of interaction was performed. To further investigate the joint association of diabetes with each factor in predicting cognitive performance, indicator variables combining the different levels of diabetes with each factor were created. These linear regression models were adjusted for age, sex, education, and all the remaining covariates.

Since BMI was missing for 51 (2.1%) participants, multiple imputation by chained equation (MICE) was done for missing data to obtain 50 datasets. We pooled the estimates using Rubin's rule to obtain valid statistical inferences \[[@ref018]\]. The sampling was corrected by introducing weights based on the age--and sex--specific structure of the adult population aged ≥ 60 years in the Kungsholmen area in 2001 (women 65.6% and men 34.4%) in all analyses. All tests were two-tailed and *p* values \<0.05 were considered statistically significant. Statistical analyses were performed with Stata SE 14.0 (StataCorp LP, College Station, Texas, USA).

RESULTS {#sec0045}
=======

Characteristics of study population {#sec0050}
-----------------------------------

Of all participants, 196 (8.5%) had diabetes, of which 144 (73.5%) with uncontrolled diabetes, and 571 (24.8%) persons had prediabetes. The prevalence of diabetes was comparable with that of another elderly Swedish population \[[@ref019]\]. Among participants with diabetes, 121 (61.7%) reported treatment with hypoglycemic medications and/or diet. In comparison to diabetes-free people, participants with diabetes or prediabetes were more likely to be older, men, less educated, to have more vascular disorders and higher BMI, to be physically active, and to have lower MMSE scores ([Table 1](#jad-53-jad160266-t001){ref-type="table"}). Compared to diabetes-free participants, those with diabetes had lower performance in all cognitive domains, and individuals with prediabetes had lower performance in most cognitive domains ([Fig. 2](#jad-53-jad160266-g002){ref-type="fig"}).

Diabetes and cognitive functioning {#sec0055}
----------------------------------

In basic-adjusted (by age, sex, and education) linear regressions, diabetes, mainly uncontrolled, was significantly associated with poorer performance in MMSE, perceptual speed, category fluency, and digit span forward, but not in letter fluency, semantic and episodic memory, or digit span backward ([Table 2](#jad-53-jad160266-t002){ref-type="table"}). In multi-adjusted (by age, sex, education, vascular disorders, depression, VRFs, and physical activity) models, the association between diabetes and digit span forward remained significant (β--coefficient (β) -- 0.21, 95% CI -- 0.39, -- 0.02; *p* = 0.027), although diabetes was not significantly related to any other cognitive task ([Supplementary Table 1](#S1){ref-type="supplementary-material"}). There was no reliable association between prediabetes and cognitive performance ([Table 2](#jad-53-jad160266-t002){ref-type="table"}). In the multinomial logistic regression, when cognitive functioning for each domain was divided into tertiles, diabetes, especially uncontrolled diabetes, was significantly related to increased odds of low (lowest tertile) performance in perceptual speed (Odds Ratio (OR) 1.94, 95% CI 1.15, 3.27; *p* = 0.014) compared to high (highest tertile) performance in the same domain.

Role of VRFs, vascular disorders, and APOE *ɛ*4 in the diabetes-cognition link {#sec0060}
------------------------------------------------------------------------------

In stratified analyses by vascular disorders, depression, *APOE* *ɛ*4, VRFs, and physical activity, the relationship of diabetes to perceptual speed and category fluency were present only among participants with VRFs, vascular disorders, or *APOE* *ɛ*4 non-carriers ([Table 3](#jad-53-jad160266-t003){ref-type="table"}). However, the association between diabetes and digit span forward remained of the same magnitude and statistically significant among participants with and without overweight/obesity or vascular disorders; therefore, this association was not altered by VRFs or vascular disorders. Further, in the stratified analysis by age (younger old \<78 years versus older old ≥ 78 years), the significant associations of diabetes with perceptual speed and category fluency were present only in the younger old cohort ([Supplementary Figure 1](#S1){ref-type="supplementary-material"}), whereas the association of diabetes with digit span forward remained consistently significant in both age groups. There was a statistically significant interaction of diabetes with *APOE* *ɛ*4 (*p* = 0.020) in predicting digit span forward performance. Participants with diabetes who were *ɛ*4 non-carriers had poorer performance on digit span forward than those with diabetes who were *ɛ*4 carriers. We further investigated the joint association of diabetes and VRFs, vascular disorders, or *APOE* status in predicting cognitive performance across the different domains ([Table 3](#jad-53-jad160266-t003){ref-type="table"}). The association between perceptual speed or category fluency performance and diabetes was independently different across levels of smoking, overweight/obesity, and vascular disorders.

Supplementary analyses {#sec0065}
----------------------

Among participants with diabetes, oral hypoglycemic medication use was associated with an increased odds of low cognitive performance in category fluency (OR 47.2, 95% CI 5.22, 426.3; *p* = 0.001) and letter fluency (OR 6.4, 95% CI 1.24, 32.66; *p* = 0.027); insulin use was associated with increased odds for low digit span forward performance (OR 11.6, 95% CI 1.14, 117.4; *p* = 0.038), and tight glycemic control (HbA1c \<6.5% versus HbA1c ≥ 6.5%) was linked to increased odds of low cognitive performance in digit span forward (OR 5.6, 95% CI 1.29, 24.54; *p* = 0.022), after multi--adjustment for age, sex, education, VRFs, vascular disorders, physical activity, and *APOE* *ɛ*4. There was no statistically significant association between duration of diabetes and cognitive performance. Differences in mean cognitive performance by glycemic status among participants with diabetes were further examined. Although individuals with uncontrolled diabetes had lower cognitive performance than those with controlled diabetes, there were no statistically significant differences ([Supplementary Figure 2](#S1){ref-type="supplementary-material"}). We also assessed whether participants with diabetes had different cognitive performance by blood pressure management; no statistically significant differences were observed (data not shown).

The percentage of *ɛ*4 carriers was 28.1% (626/2228) among study participants, whereas it was 36.6% (104/286) among the cognitively impaired participants who were excluded (*p* = 0.004). Comparing characteristics of *APOE* *ɛ*4 carriers and non-carriers, no significant differences in terms of HbA1c, VRFs, vascular disorders, physical activity, or cognitive performance were observed. Analyses using imputed BMI data produced similar results.

DISCUSSION {#sec0070}
==========

In this population-based study of cognitively intact older adults, we found that: 1) diabetes, especially uncontrolled, but not prediabetes, was associated with poorer performance in perceptual speed, category fluency, and attention/primary memory; 2) these associations were only found in *APOE* *ɛ*4 non-carriers; and 3) the associations of diabetes with perceptual speed and category fluency were present only among older people with VRFs or vascular disorders. Our findings suggest that diabetes might affect cognitive domains differently, and some domains may be more sensitive to diabetes than others.

In the present study, where individuals with CIND and preclinical dementia were excluded, we observed an effect of diabetes on perceptual speed, category fluency, and attention/primary memory, suggesting that these three domains may be primarily affected by diabetes. Previous research examining the relation between diabetes and cognitive functioning has produced equivocal findings \[[@ref002]\]. Some clinical studies in non-demented older adults showed that diabetes was associated with impaired processing speed, executive function, and episodic memory \[[@ref020]\], although other studies did not find such associations \[[@ref002]\]. An Italian population-based study revealed lower MMSE performance, selective attention, and verbal memory in older women with diabetes compared to those without diabetes \[[@ref022]\]. However, in these studies CIND was not excluded. Therefore, as cognitive impairment represents an intermediate stage between healthy aging and dementia \[[@ref023]\], the observed cognitive deficits associated with diabetes may not represent the initial domains affected, but rather reflect cognitive changes due to causes other than diabetes, such as an underlying degenerative neuropathology.

In addition to lowering the risk of vascular diseases, effective glycemic control may lower the risk of several diabetes-related complications, such as neuropathy. Most studies examining the relation between diabetes and cognitive functioning have not taken glycemic control into account. However, a few studies have reported that diabetes--related cognitive deficits may be attenuated by effective glycemic control \[[@ref024]\]. In our study of cognitively intact older adults, uncontrolled diabetes was associated with poorer performance in perceptual speed, but not in episodic and semantic memory. A possible explanation for the lack of association between diabetes and semantic memory is the differential effects of aging and age-related diseases on crystallized abilities (such as semantic memory) and fluid abilities (such as speed and fluency). In normal cognitive aging, crystallized abilities are much more resistant to age effects than fluid abilities \[[@ref026]\]. Analogously, the effect of age-related diseases such as diabetes may affect speed and category fluency, but not semantic memory, as shown in the current study. Therefore, fluid abilities might be more sensitive to the effects of both age--related changes and diabetes, especially hyperglycemia. Deficits in perceptual speed could reflect abnormalities in white-matter connectivity, which may be caused by long-term chronic hyperglycemia \[[@ref027]\]. Indeed, a recent study in a subsample of SNAC--K showed a link between diabetes and microstructural white-matter integrity \[[@ref028]\]. Category fluency involves speed, working memory, and executive function components. A recent study observed altered functional brain activation in the frontal cortex during a working memory task in people with diabetes \[[@ref029]\]. In line with this finding, we found an association of diabetes with category fluency. Although episodic memory may be considered a fluid ability, we failed to detect a significant association with diabetes, probably due to the episodic memory task in SNAC-K being demanding for all participants. This raises an important general point regarding group comparisons in neuropsychological research, namely that the performance level of the control group (in this case, diabetic-free people) in a specific task is as important to consider as the performance level of a clinical group.

The digit span test includes two tasks, forward and backward. Although they measure partly different cognitive skills, both depend on short-term memory \[[@ref017]\]. However, digit span forward seems to resist deleterious effects of several conditions, such as cognitive decline in normal aging and early stages of dementia, whereas digit span backward is typically more sensitive to neurodegenerative changes and tends to show a more age-related decline compared to the forward task \[[@ref017]\]. A meta-analysis has shown that diabetes is associated with poorer performance in both digits forward and backward \[[@ref002]\]. We found a robust association between uncontrolled diabetes and lower performance in digit span forward, but not backward. Although this pattern might appear paradoxical, a possible explanation is that digits backward is considerably more demanding than digits forward \[[@ref017]\]. Thus, digits backward may have been highly taxing for participants with and without diabetes alike, thus resulting in failure to detect significant group differences.

Hyperglycemia is one of the mechanisms whereby diabetes could cause cognitive deficits. Chronic exposure to high levels of glucose leads to selective death of neurons, which obviously may lead to cognitive deficits \[[@ref031]\]. First, chronic hyperglycemia is accompanied by insulin-resistance and compensatory peripheral hyperinsulinemia \[[@ref032]\]. Second, hyperglycemia may increase oxidative stress, which stimulates the release of cytokines and other inflammatory agents promoting chronic inflammation and endothelial dysfunction leading to cerebral microvascular damage \[[@ref033]\]. Third, in specific brain regions, hyperglycemia can induce progressive changes in the permeability of the blood brain barrier and progressively increase the susceptibility of the barrier to cerebral micro-vessel damages that may disrupt homeostasis and result in cognitive deficits \[[@ref034]\]. On the other hand, tight glycemic control increases the risk of hypoglycemia -- an additional mechanism that may underlie cognitive deficits in diabetes. Towards this end, antidiabetic medications, which focus on lowering blood sugar, are among the most common causes of hypoglycemia in older diabetic people \[[@ref035]\].

Smoking, being overweight or obese, vascular disorders, and *APOE* *ɛ*4 are all risk factors for diabetes \[[@ref036]\]. After controlling for VRFs and vascular disorders, the relationship of diabetes to perceptual speed and category fluency was attenuated and no longer significant suggesting that these behavioral and clinical factors contributed to the relationships observed in the initial analyses. In the stratified analyses we found that the negative associations between diabetes and cognitive performance were present only among individuals with VRFs and vascular disorders. Thus, VRFs and vascular disorders could modulate the effect of diabetes on cognitive functioning at early stages before the manifestation of overt cognitive impairment. Therefore, at least in the initial phases, diabetes may not be the sole actor; other factors may cause cognitive impairment.

Two population-based longitudinal studies have shown an association between diabetes and increased risk of dementia only among the *APOE* *ɛ*4 non-carriers \[[@ref037]\]. Relatedly, our results showed that the negative associations between diabetes and cognitive performance were present only in *ɛ*4 non-carriers. A possible explanation for this finding is that people possessing an *ɛ*4 allele deposit amyloid-β at a faster rate and have a higher amount of amyloid than those without this allele \[[@ref038]\]. Thus, *APOE* *ɛ*4 carriers may accumulate sufficient pathology to bring them to the threshold for expressing cognitive impairment or dementia, whereas *ɛ*4 non-carriers require further physiological insults, such as diabetes, to bring them to this threshold \[[@ref038]\]. In support of this hypothesis, we found a greater proportion of *ɛ*4 carriers among the cognitively impaired participants, who were excluded from the study, than among the cognitively intact participants.

The main strengths of our study are: 1) the community-based cohort design; 2) the comprehensive assessment of cognitive functioning and dementia diagnosis, which enabled us to identify cognitively intact people; 3) the use of latent variables in measuring cognitive performance, thereby removing error variance associated with specific tasks; and 4) the evaluation of the association of diabetes with cognitive performance taking glycemic control and *APOE* into account. However, some limitations should be noted. First, the cross-sectional design raises concerns as to the temporal nature of the observed associations. Second, we used HbA1c to detect undiagnosed diabetes (diabetes in diabetes-free participants). As the receiver operating curve is 0.895 (95% CI 0.861, 0.930) for detecting diabetes using HbA1c \[[@ref040]\], participants with impaired glucose tolerance might have been misclassified as diabetes-free, which would bias the results in the direction of reducing group differences. Third, as the age range of participants is 60 years and older, the generalizability of our results is restricted to this age span. Finally, we were unable to examine the role of insulin-resistance, specific antidiabetic drugs, brain atrophy and lesions in the association of diabetes with cognitive impairment, due to lack of available data for the present sample or the absence of blood-insulin measurement in SNAC--K.

In conclusion, our findings provide evidence that diabetes may affect certain cognitive domains (perceptual speed, category fluency, and attention/primary memory) before other domains. The identification of a combination of well-defined cognitive components affected by diabetes is relevant for several reasons. These include early diagnosis and health care planning, aiding in the selection of appropriate cognitive tests in order to optimize the time and not to stress the patient, and the ability to predict the possible progression from cognitive deficits to cognitive impairment and dementia.

In addition, VRFs, vascular disorders, and *APOE* *ɛ*4 play an important role in the diabetes--cognition association. Identification of these factors helps to provide insight into differences among patients in order to identify which diabetic patient would require a more detailed neurological investigation. Our study also highlights the need for better control of blood glucose and VRFs, and an effective treatment of vascular disorders in order to prevent cognitive impairment and dementia in older adults with diabetes.
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======================
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The authors would like to express their gratitude to the participants and staff involved in the data collection and management in the SNAC-K study. In addition, we are grateful to Emerald Heiland, Aging Research Center, Karolinska Institutet, for her valuable suggestions on the English in the manuscript.

SNAC-K is financially supported by the Swedish Ministry of Health and Social Affairs, the participating County Councils and Municipalities, and the Swedish Research Council. Additional funding was received from the Swedish Research Council for Health, Working Life and Welfare, the Board of Research Karolinska Institute, Ragnhild and Einar Lundströms Minne Lindhés Foundation, Diabetesfonden, the Stiftelsen För Gamla Tjänarinnor, the Gun och Bertil Stohnes Stiftelse (Sweden), Strokefonden, the American Federation for Aging Research (USA), and Karolinska Instituetet (KID-funding). L. Bäckman was also supported by an Alexander von Humboldt Research Award and a donation from the af Jochnick Foundation.

Authors' disclosures available online (<http://j-alz.com/manuscript-disclosures/16-0266r1>).

The supplementary material is available in the electronic version of this article: <http://dx.doi.org/10.3233/JAD-160266>.

![Flowchart of the baseline study population in SNAC--K. MMSE, Mini-Mental State Examination.](jad-53-jad160266-g001){#jad-53-jad160266-g001}

![Cognitive characteristics of the study sample by diabetes. Pairwise multiple comparisons: ^\*^*p*\<0.05 (reference group included diabetes-free participants). All latent factor scores were multiplied by 100. Missing data: 48 for perceptual speed, 8 for category fluency, 11 for letter fluency, 6 for semantic memory, 20 for episodic memory, 57 for digit span forward, and 62 for digit span backward.](jad-53-jad160266-g002){#jad-53-jad160266-g002}

###### 

Sociodemographic, clinical, and lifestyle related characteristics of the study sample (*n* = 2305) by diabetes status

  Characteristics           Diabetes-free        Prediabetes          Diabetes       *p*
  ---------------------- ------------------- ------------------- ------------------- ----------
  Age (y)                       71±10               74±10               73±9         \< 0.001
  Female                     965 (62.7)          372 (65.2)           86 (43.9)      \< 0.001
  Education                                                                          
  Low (≤8 y)                 288 (18.7)          155 (27.2)           57 (29.1)      \< 0.001
  High (\>8 y)               1250 (81.3)         416 (72.9)          139 (70.9)      
  MMSE, mean (SD)             29.0±1.0            29.0±1.0            28.0±2.0       \< 0.001
  Hypertension               1094 (71.2)         450 (79.0)          173 (88.3)      \< 0.001
  Heart disease              366 (23.8)          193 (33.8)           98 (46.9)      \< 0.001
  Stroke                      102 (6.6)           53 (9.3)            18 (9.2)       0.079
  Depression                  58 (3.8)            11 (1.9)             5 (2.6)       0.088
  HbA1c (%)^\*^            5.4 (5.2--5.6)      5.9 (5.8--6.1)      7.1 (6.3--7.3)    \< 0.001
  Any *APOE* *ɛ*4            422 (28.7)          155 (28.7)           42 (22.7)      0.217
  BMI (kg/m^2^)^\*^       25.1 (23.0--27.6)   25.8 (23.5--28.5)   27.7 (24.8--30.6)  \< 0.001
  Underweight (\<18.5)        71 (4.6)            21 (3.7)             8 (4.1)       \< 0.001
  Normal (18.5--25)          666 (43.3)          207 (36.3)           44 (22.5)      
  Overweight (25--30)        625 (40.6)          232 (40.6)           76 (38.8)      
  Obese (≥30)                 152 (9.9)           98 (17.2)           63 (32.1)      
  Missing                     24 (1.6)            13 (2.3)             5 (2.6)       
  Current smoking            832 (54.4)          312 (54.8)          115 (59.3)      0.434
  Alcohol drinking           1189 (77.4)         354 (62.2)          120 (61.9)      \< 0.001
  Physically active          328 (21.3)          159 (27.9)           72 (36.7)      \< 0.001

Data are presented as mean±SD, *n* (%), or ^\*^median (25th-- 75th percentile; *p* calculated with quantile regression). Missing data: 2 for hypertension, and 113 for *APOE*. *APOE*, apolipoprotein; BMI, body mass index; HbA1c, glycated hemoglobin; MMSE, Mini-Mental State Examination; SD, standard deviation.

###### 

Mean differences (β-- coefficients) and 95% confidence intervals (CIs) of the association between diabetes and cognitive performance across domains

  Diabetes        *n*                MMSE               Perceptual speed         Category fluency         Letter fluency                                                                     
  -------------- ------ ------------------------------ ------------------ ------------------------------ ---------------- ------------------------------ ------- --------------------------- -------
  No              1538            Reference                Reference                Reference               Reference                                                                        
  Prediabetes     571     -- 0.01 (-- 0.12 to 0.12)          0.913          -- 0.23 (-- 0.78 to 0.32)         0.417           0.05 (-- 0.75 to 0.85)      0.899   -- 0.17 (-- 1.02 to 0.68)   0.696
  Diabetes        196     -- 0.16 (-- 0.32 to 0.01)          0.059         -- 1.10 (-- 1.98 to -- 0.23)       0.014        -- 1.27 (-- 2.52 to -- 0.03)   0.045   -- 0.77 (-- 2.08 to 0.54)   0.250
  Controlled       52     -- 0.03 (-- 0.34 to 0.29)          0.864          -- 0.54 (-- 2.41 to 1.32)         0.569         -- 0.91 (-- 2.87 to 1.05)     0.362   -- 0.36 (-- 2.63 to 1.92)   0.758
  Uncontrolled    144    -- 0.21 (-- 0.39 to -- 0.02)        0.030         -- 1.31 (-- 2.25 to -- 0.37)       0.006         -- 1.40 (-- 2.89 to 0.09)     0.065   -- 0.92 (-- 2.45 to 0.62)   0.241

  Diabetes       Semantic memory   Episodic memory             Digit span forward   Digit span backward                                                                                        
  -------------- ----------------- --------------------------- -------------------- --------------------------- ----------- ------------------------------ ------- --------------------------- -------
  No             1538              Reference                   Reference            Reference                   Reference                                                                      
  Prediabetes    571               -- 0.69 (-- 1.60 to 0.23)   0.140                0.24 (-- 0.47 to 0.95)      0.505       -- 0.01 (-- 0.14 to 0.11)      0.853   0.02 (-- 0.09 to 0.14)      0.694
  Diabetes       196               -- 0.61 (-- 1.97 to 0.75)   0.379                -- 0.48 (-- 1.64 to 0.68)   0.418       -- 0.35 (-- 0.54 to -- 0.17)   0.000   -- 0.14 (-- 0.31 to 0.04)   0.119
  Controlled     52                1.11 (-- 1.01 to 3.22)      0.305                -- 0.72 (-- 1.22 to 2.66)   0.470       -- 0.38 (-- 0.72 to -- 0.04)   0.031   -- 0.13 (-- 0.41 to 0.14)   0.337
  Uncontrolled   144               -- 1.22 (-- 2.84 to 0.39)   0.138                -- 0.92 (-- 2.28 to 0.44)   0.184       -- 0.35 (-- 0.56 to -- 0.14)   0.001   -- 0.14 (-- 0.34 to 0.07)   0.185

Basic--adjusted model: adjusted for age, sex, and education. MMSE, Mini-Mental State Examination.

###### 

Multivariable--adjusted mean differences (β-- coefficients) and 95% confidence intervals (CIs) across cognitive domains, according to specific joint levels of diabetes with smoking, overweight/obesity (BMI ≥25), vascular disorders, or *APOE* status

  Factors        Diabetes             MMSE              Perceptual speed         Category fluency         Digit span forward                                                                        
  ------------- ---------- --------------------------- ------------------ ------------------------------ -------------------- ------------------------------ ------- ------------------------------ -------
  Smoking                                                                                                                                                                                           
    No              No              Reference                                       Reference                                           Reference                              Reference            
    No             Yes       0.07 (-- 0.18 to 0.31)          0.600          -- 0.05 (-- 1.32 to 1.38)           0.946             0.46 (-- 1.27 to 2.20)      0.600   -- 0.33 (-- 0.64 to -- 0.02)   0.037
    Yes             No       0.04 (-- 0.07 to 0.15)          0.525            0.23 (-- 0.38 to 0.83)            0.453             0.46 (-- 0.39 to 1.33)      0.290      0.05 (-- 0.09 to 0.18)      0.490
    Yes            Yes      -- 0.15 (-- 0.36 to 0.05)        0.144         -- 1.59 (-- 2.50 to -- 0.35)         0.004          -- 1.69 (-- 3.21 to -- 0.18)   0.029    -- 0.15 (-- 0.38 to 0.10)     0.200
  BMI ≥25                                                                                                                                                                                           
    No              No              Reference                                       Reference                                           Reference                              Reference            
    No             Yes       0.06 (-- 0.20 to 0.32)          0.644          -- 0.27 (-- 1.85 to 1.32)           0.742           -- 0.56 (-- 2.87 to 1.75)     0.633   -- 0.44 (-- 0.80 to -- 0.07)   0.019
    Yes             No       0.04 (-- 0.05 to 0.12)          0.359            0.02 (-- 0.51 to 0.54)            0.949             0.13 (-- 0.64 to 0.91)      0.741   -- 0.22 (-- 0.34 to -- 0.09)   0.001
    Yes            Yes      -- 0.07 (-- 0.23 to 0.08)        0.356         -- 1.63 (-- 2.58 to -- 0.67)         0.001           -- 1.36 (-- 2.75 to 0.04)     0.058   -- 0.41 (-- 0.63 to -- 0.19)   0.000
  Vascular                                                                                                                                                                                          
  disorders                                                                                                                                                                                         
    No              No              Reference                                       Reference                                           Reference                              Reference            
    No             Yes      -- 0.01 (-- 0.20 to 0.17)        0.904          -- 0.68 (-- 1.80 to 0.43)           0.231           -- 1.21 (-- 2.86 to 0.44)     0.151   -- 0.33 (-- 0.59 to -- 0.07)   0.014
    Yes             No      -- 0.02 (-- 0.12 to 0.08)        0.680         -- 0.97 (-- 1.57 to -- 0.37)         0.001          -- 1.14 (-- 2.02 to -- 0.26)   0.011    -- 0.10 (-- 0.24 to 0.04)     0.171
    Yes            Yes      -- 0.15 (-- 0.33 to 0.03)        0.104         -- 2.90 (-- 4.01 to -- 1.80)         0.000          -- 2.44 (-- 4.05 to -- 0.83)   0.003   -- 0.28 (-- 0.53 to -- 0.02)   0.033
  *APOE* *ɛ*4                                                                                                                                                                                       
    No              No              Reference                                       Reference                                           Reference                              Reference            
    No             Yes      -- 0.14 (-- 0.34 to 0.05)        0.138         -- 1.11 (-- 2.15 to -- 0.06)         0.038           -- 1.07 (-- 2.42 to 0.29)     0.123   -- 0.36 (-- 0.58 to -- 0.14)   0.001
    Yes             No      -- 0.04 (-- 0.16 to 0.08)        0.523          -- 0.86 (-- 1.47 to 0.25)           0.006             0.27 (-- 0.68 to 1.22)      0.576    -- 0.05 (-- 0.20 to 0.11)     0.554
    Yes            Yes       0.18 (-- 0.02 to 0.37)          0.076          -- 1.31 (-- 2.89 to 0.25)           0.100             0.08 (-- 2.15 to 2.32)      0.941      0.04 (-- 0.32 to 0.41)      0.814

Four separate models are presented in this table. In each model, we introduced an interaction term between diabetes and one of the factors adjusted for age, sex, education, and all the remaining factors. *APOE*, apolipoprotein; BMI, body mass index; MMSE, Mini-Mental State Examination.
